Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3801 USD | +5.58% | -10.56% | -97.92% |
05-17 | North American Morning Briefing : The "Everything -2- | DJ |
05-15 | Transcript : Panbela Therapeutics, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Evolution of the average Target Price on Panbela Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Panbela Therapeutics, Inc.
HC Wainwright | |
Maxim | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- SNBP Stock
- Consensus Panbela Therapeutics, Inc.